SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Anika Therapeutics, Inc. – ‘PREC14A’ on 3/27/23 re: Anika Therapeutics, Inc. – ‘ZIP’

On:  Monday, 3/27/23, at 8:48am ET   ·   Accession #:  1193125-23-79887   ·   File #:  1-14027

1 Reference:  By:  SEC – ‘UPLOAD’ on 4/4/23

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 3/27/23  Anika Therapeutics, Inc.          PREC14A               12:7.2M Anika Therapeutics, Inc.          Donnelley … Solutions/FA

Preliminary Proxy Statement – Contested Solicitation   —   Schedule 14A

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: PREC14A     Preliminary Proxy Statement - Contested             HTML    700K 
                Solicitation                                                     
 6: R1          Cover                                               HTML     16K 
 7: R2          Pay vs Performance Disclosure                       HTML    254K 
10: XML         IDEA XML File -- Filing Summary                      XML     20K 
 8: XML         XBRL Instance -- d480900dprec14a_htm                 XML    348K 
 9: EXCEL       IDEA Workbook of Financial Reports                  XLSX     12K 
 3: EX-101.DEF  XBRL Definitions -- anik-20221231_def                XML     20K 
 4: EX-101.LAB  XBRL Labels -- anik-20221231_lab                     XML     24K 
 5: EX-101.PRE  XBRL Presentations -- anik-20221231_pre              XML     18K 
 2: EX-101.SCH  XBRL Schema -- anik-20221231                         XSD     18K 
11: JSON        XBRL Instance as JSON Data -- MetaLinks              101±   117K 
12: ZIP         XBRL Zipped Folder -- 0001193125-23-079887-xbrl      Zip   1.66M 


‘ZIP’   —   XBRL Zipped Folder — 0001193125-23-079887-xbrl


This is an XBRL Zipped Folder.

        Download this zipped .zip folder
 
Files:anik-20221231.xsd
anik-20221231_def.xml
anik-20221231_lab.xml
anik-20221231_pre.xml
d480900dprec14a.htm
g480900g00h00.jpg
g480900g00k09.jpg
g480900g01a99.jpg
g480900g01h01.jpg
g480900g01h02.jpg
g480900g01h03.jpg
g480900g01h08.jpg
g480900g01h12.jpg
g480900g01h15.jpg
g480900g01h16.jpg
g480900g01h17.jpg
g480900g01h18.jpg
g480900g01h19.jpg
g480900g01h20.jpg
g480900g01h21.jpg
g480900g01h27.jpg
g480900g01h29.jpg
g480900g01h62.jpg
g480900g02a99.jpg
g480900g02h08.jpg
g480900g02h18.jpg
g480900g03h08.jpg


1 Subsequent Filing that References this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 4/04/23  SEC                               UPLOAD8/04/23    2:43K  Anika Therapeutics, Inc.
Top
Filing Submission 0001193125-23-079887   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Fri., May 3, 1:04:15.2am ET